Compare IMA & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMA | ZEPP |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 56.6M |
| IPO Year | 2021 | 2017 |
| Metric | IMA | ZEPP |
|---|---|---|
| Price | $4.11 | $2.27 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 12.1K | ★ 63.8K |
| Earning Date | 11-20-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | $14.24 |
| Revenue Next Year | N/A | $6.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.88 | $2.15 |
| 52 Week High | $8.84 | $32.85 |
| Indicator | IMA | ZEPP |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 23.97 |
| Support Level | $3.91 | $2.19 |
| Resistance Level | $6.13 | $5.57 |
| Average True Range (ATR) | 0.22 | 0.23 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 39.48 | 25.95 |
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.